Author:
Tang Shanhao,Shen Hongjie,Mao Xinliang,Dai Haiping,Zhu Xiaming,Xue Shengli,Ding Zixuan,Lu Jing,Wu Depei,Tang Xiaowen
Funder
National Natural Science Foundation of China
Applied basic research of Suzhou science and technology progra
Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and The national key research and development program
Innovation Capability Development Project of Jiangsu Province
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Goryainova NV. The clinical significance of genetic mutations in acute myeloid leukemia. Lik Sprava. 2014;12:10–8.
2. Volpe G, Clarke M, Garcia P, Walton DS, Vegiopoulos A, Del Pozzo W, et al. Regulation of the Flt3 gene in haematopoietic stem and early progenitor cells. PLoS One. 2015;10(9):e0138257.
3. Pemmaraju N, Kantarjian H, Andreeff M, Cortes J, Ravandi F. Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemia. Expert Opin Investig Drugs. 2014;23(7):943–54.
4. Govedarovic N, Marjanovic G. Frequency and prognostic impact of FLT3/ITD mutation in patients with acute myeloid leukaemia. J BUON. 2011;16(1):108–11.
5. Peng HL, Zhang GS, Gong FJ, Shen JK, Zhang Y, Xu YX, et al. Fms-like tyrosine kinase (FLT) 3 and FLT3 internal tandem duplication in different types of adult leukemia: analysis of 147 patients. Croat Med J. 2008;49(5):650–69.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献